These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1518996)

  • 1. Withdrawal censoring and the sequential logrank procedure.
    Richardson DJ
    Stat Med; 1992 Jul; 11(10):1359-66. PubMed ID: 1518996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing for differences in changes in the presence of censoring: parametric and non-parametric methods.
    Wu MC; Hunsberger S; Zucker D
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):635-46. PubMed ID: 8023039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of unequal censoring on the size and power of the logrank and Wilcoxon types of tests for survival data.
    Beltangady MS; Frankowski RF
    Stat Med; 1989 Aug; 8(8):937-45. PubMed ID: 2799123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A useful design utilizing the information fraction in a group sequential clinical trial with censored survival data.
    Hsu CY; Chen CH; Hsu KN; Lu YH
    Biometrics; 2019 Mar; 75(1):133-143. PubMed ID: 30004574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size for comparison of changes in the presence of right censoring caused by death, withdrawal, and staggered entry.
    Wu MC
    Control Clin Trials; 1988 Mar; 9(1):32-46. PubMed ID: 3356151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive trial design: a general methodology for censored time to event data.
    Jahn-Eimermacher A; Ingel K
    Contemp Clin Trials; 2009 Mar; 30(2):171-7. PubMed ID: 19130902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General right censoring and its impact on the analysis of survival data.
    Lagakos SW
    Biometrics; 1979 Mar; 35(1):139-56. PubMed ID: 497332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes.
    Sugimoto T; Hamasaki T; Evans SR; Halabi S
    Lifetime Data Anal; 2020 Apr; 26(2):266-291. PubMed ID: 30980317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing sample size formulae for trials with unbalanced allocation using the logrank test.
    Hsieh FY
    Stat Med; 1992 Jun; 11(8):1091-8. PubMed ID: 1496196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for the analysis of informatively censored longitudinal data.
    Schluchter MD
    Stat Med; 1992; 11(14-15):1861-70. PubMed ID: 1480878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of logrank tests and group sequential methods at fixed calendar times.
    DeMets DL; Gail MH
    Biometrics; 1985 Dec; 41(4):1039-44. PubMed ID: 4096915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General independent censoring in event-driven trials with staggered entry.
    Rühl J; Beyersmann J; Friedrich S
    Biometrics; 2023 Sep; 79(3):1737-1748. PubMed ID: 35762259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of sample size calculations based on a comparison of proportions for use with the logrank test.
    Gail MH
    Control Clin Trials; 1985 Jun; 6(2):112-9. PubMed ID: 4006484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of sample size methods for the logrank statistic.
    Lakatos E; Lan KK
    Stat Med; 1992 Jan; 11(2):179-91. PubMed ID: 1579757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing complex group sequential survival trials.
    Lakatos E
    Stat Med; 2002 Jul; 21(14):1969-89. PubMed ID: 12111882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size calculation for the weighted rank statistics with paired survival data.
    Jung SH
    Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobit regression for modeling mean survival time using data subject to multiple sources of censoring.
    Gong Q; Schaubel DE
    Pharm Stat; 2018 Mar; 17(2):117-125. PubMed ID: 29359427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Power comparisons for group sequential tests with nonparametric statistics in case of nonproportional hazards.
    Demirhan H; Demirhan YP; Bacanli S
    J Biopharm Stat; 2013 Mar; 23(2):447-60. PubMed ID: 23437950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.